Prevalence and association of hepatitis C viremia in hemodialysis patients at a tertiary care hospital

Indian Journal of Nephrology

Volumn 19, Issue 4, 2009, Pages 172-173

  Agarwal, S K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; LIVER ENZYME; TUBERCULOSTATIC AGENT;

DIAGNOSTIC ACCURACY; DIALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; HEALTH PROGRAM; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY FAILURE; LETTER; METHODOLOGY; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; TERTIARY HEALTH CARE; TUBERCULOSIS; VACCINATION;

EID: 77953404505     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.59343     Document Type: Letter

References (14)

1. Jasuja S, Gupta AK, Choudhary R, Kher V, Agarwal DK, Misra A, et al. Prevalence and association of hepatitis C viremia in hemodialysis patients at a tertiary care hospital. Indian J Nephrol 2009;19:62-68
2. Medhi S, Potukuchi SK, Polipalli SK, Swargiary SS, Deka P, Chaudhary A, et al. Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients. Clin Biochem 2008;41:447-452
3. Lakshmi V, Reddy AK, Dakshinamurty KV. Evaluation of commercially available third-generation anti-hepatitis C virus enzyme-linked immunosorbent assay in patients on haemodialysis. Indian J Med Microbiol 2007;25:140-142
4. Jindal N, Jindal M, Jilani N, Kar P. Seroprevalence of hepatitis C virus (HCV) in health care workers of a tertiary care centre in New Delhi. Indian J Med Res 2006;123:179-180
5. Reddy AK, Dakshinamurty KV, Lakshmi V. Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis. Indian J Med Microbiol 2006;24:55-57
6. Chattopadhyay S, Rao S, Das BC, Singh NP, Kar P. Prevalence of transfusion-transmitted virus infection in patients on maintenance hemodialysis from New Delhi, India. Hemodial Int 2005;9:362-366 (Pubitemid 41614647)
7. Reddy AK, Murthy KV, Lakshmi V. Prevalence of HCV infection in patients on haemodialysis: Survey by antibody and core antigen detection. Indian J Med Microbiol 2005;23:106-110
8. Reddy GA, Dakshinamurthy KV, Neelaprasad P, Gangadhar T, Lakshmi V. Prevalence of HBV and HCV dual infection in patients on haemodialysis. Indian J Med Microbiol 2005;23:41-43
9. Chandra M, Khaja MN, Hussain MM, Poduri CD, Farees N, Habeeb MA, et al. Prevalence of hepatitis B and hepatitis C viral infections in Indian patients with chronic renal failure. Intervirology 2004;47:374-376
10. Saha D, Agarwal SK. Hepatitis and HIV infection during haemodialysis. J Indian Med Assoc 2001;99:194-9, 203, 213.
11. Agarwal SK, Dash SC, Irshad M. Hepatitis C virus infection during haemodialysis in India. J Assoc Physicians India 1999;47:1139-1143
12. Gosavi MS, Shah SK, Shah SR, Pal RB, Saldanha JA, Banker DD. Prevalence of hepatitis C virus (HCV) infection in Mumbai. Indian J Med Sci 1997;51:378-385
13. Jaiswal SP, Chitnis DS, Naik G, Artwani KK, Pandit CS, Salgia P, et al. Prevalence of anti-HCV antibodies in central India. Indian J Med Res 1996;104:177-181
14. Arankalle VA, Chadha MS, Jha J, Amrapurkar DN, Banerjee K. Prevalence of anti-HCV antibodies in western India. Indian J Med Res 1995;101:91-93